SmallCaps
ASX:CSLPharmaceuticals, Biotechnology & Life SciencesBiotechnology

CSL Ltd

$115.870
+$3.830 (+3.42%)
Day Range
$112.670 – $117.110
52 Week Range
$90.000 – $275.790
Volume
1.26M
Avg Volume (10D)
2.76M
Market Cap
$55.49B
P/E Ratio
12.82

Price Chart

OHLC · volume · moving averages

$115.870-$55.610 (-32.43%)over 6M
Hi$184.620Lo$90.000
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today's trading range

Open
$114.470
Previous Close
$112.040
Day High
$117.110
Day Low
$112.670
52 Week High
$275.790
52 Week Low
$90.000

Valuation

Fundamental multiples

Market Cap
55.49B
Shares Outstanding
478.91M
P/E Ratio (Annual)
12.82
P/E Ratio (TTM)
27.57
Dividend Yield
2.64%
Price to Book
2.05

Trading Activity

Volume & order book

Volume
1.26M
Value Traded
145.98M
Bid
$115.860 × 67
Ask
$115.880 × 32

Performance

Returns across timeframes

1 Day
-2.96%
5 Day
6.96%
13 Week
-19.25%
52 Week
-53.01%
YTD
-34.62%

Technical Indicators

Momentum & moving averages

RSI (14)
63.70
50-Day SMA
$111.468
200-Day SMA
$159.236

— From the desk

Latest News

Want to buy some cut-price shares?
Hot Topics

Want to buy some cut-price shares?

What would your reaction be if I told you I could get you some shares at a price that is significantly less than what they are actually worth? Well, most people would say here is a wheelbarrow, fill it up with shares but as always there is something of a catch. It is possible to […]

CSL reports 25% profit increase as immunoglobulins and plasma collections lead growth
ASX 200

CSL reports 25% profit increase as immunoglobulins and plasma collections lead growth

Biotherapeutics giant CSL (ASX: CSL) has reported a net profit after tax of US$2.64 billion for the 12 months to 30 June, up 25% on a constant currency basis. Net profit after tax before amortisation was US$2.91b (up 15% on a constant currency basis), while revenue for the year was up 11% to US$14.8b. Total […]

CSL profits take US$250m hit from foreign currency movements
ASX 200

CSL profits take US$250m hit from foreign currency movements

Foreign currency movements have dented the forecast profits of multi-national biotechnology company CSL (ASX: CSL) by up to US$250 million. The company this week reported higher-than-expected headwinds, up from an estimated US$175 million reported at the time of its half year results in February. Its constant currency profit guidance for the year remains unchanged, albeit […]

Rio Tinto advances Turquoise Hill takeover, CSL to gain new boss and Telstra issues apology
ASX 200

Rio Tinto advances Turquoise Hill takeover, CSL to gain new boss and Telstra issues apology

Rio Tinto’s (ASX: RIO) share price fell at the start of the week, despite a positive update on its proposed takeover of Canadian miner Turquoise Hill Resources. The mining giant announced it received the required support from Turquoise Hill shareholders for its proposed acquisition of the remaining 49% the Canadian miner’s issued and outstanding common […]